Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.
Healixia provides training and networking opportunities for each of the 4 domains on the right.
Also discover the Healixia cross-domains events.
Healixia events
-
18 October '22Webinar: The sources of life sciences regulations - part II: Medicinal products
OnlineRead moreThis session is the second part of a two-part training course on the “Sources of life sciences regulation”. It serves to provide participants with a high-level overview of the rules and regulations applicable to medicinal products for human use in the European Union. The session will include a specific part on the Belgian legislation. It will also provide the audience with practical tips on researching applicable laws.
-
27 October '22Healixia Essentials: the role and impact of the MSL (Medical Science Liaison) explained.
OnlineRead moreThe how, the why and the who: all you would like to know about the MSL (Medical Science Liaison). This webinar is aimed at life science professionals who are not very familiar with this role or who would like to learn more on it.
-
01 December '22
Healixia Essentials: How does pharma.be defend the interests of the innovative pharma industry in Belgium?
BrusselsRead moreFace-to-face lunchmeeting.
pharma.be is the voice of the innovative Belgian - human and veterinary medicine - pharmaceutical industry. As interest group it represents 130 both small and large innovative pharmaceutical and biotech companies and is the centre of excellence for the industry.
Come and learn more on how exactly pharma.be works to defend the interests of the pharma industry in Belgium and take the opportunity to meet your peers.
News
We thank our partners for their support:
 |
 |
 |
 |